HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

4- methyl- 5- (2- (4- morpholinophenylamino)pyrimidin- 4- yl)thiazol- 2- amine

an aurora kinase inhibitor; structure in first source
Also Known As:
CYC 116; CYC-116; CYC116
Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Meng, Hai-tao: 1 article (08/2015)
2. Zhou, Yu-hong: 1 article (08/2015)
3. Feng, Jin-yi: 1 article (08/2015)
4. Qian, Wen-bin: 1 article (08/2015)
5. You, Liang-shun: 1 article (08/2015)
6. Hajduch, Marian: 1 article (01/2013)
7. Kollareddy, Madhu: 1 article (01/2013)
8. Gadher, Suresh Jivan: 1 article (01/2013)
9. Kovarova, Hana: 1 article (01/2013)
10. Tyleckova, Jirina: 1 article (01/2013)

Related Diseases

1. Neoplasms (Cancer)
2. Polyploidy
3. Multiple Myeloma
4. Colonic Neoplasms (Colon Cancer)

Related Drugs and Biologics

1. Glycine Hydroxymethyltransferase (Serine Hydroxymethyltransferase)
2. Phosphotransferases (Kinase)
3. 4- (4- (N- benzoylamino)anilino)- 6- methoxy- 7- (3- (1- morpholino)propoxy)quinazoline
4. matrine
5. compound 18